Sign In
Buy ATRC
$26.20
+0.340 (+1.31%)
At Close: Jun 03, 2026
AtriCure's (ATRC) CEO Mike Carrel on Q2 2021 Results - Earnings Call Transcript
05:38pm, Saturday, 07'th Aug 2021
AtriCure's (ATRC) CEO Mike Carrel on Q2 2021 Results - Earnings Call Transcript
AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates
07:04pm, Wednesday, 04'th Aug 2021
AtriCure (ATRC) delivered earnings and revenue surprises of -9.09% and 15.91%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
AtriCure to Participate at the Canaccord 41st Annual Growth Conference
08:00am, Friday, 30'th Jul 2021
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that
These are Wall Street's top analysts favorite stocks heading into June
08:24am, Sunday, 30'th May 2021
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Deere & Advanced Micro Devices.
AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock?
07:31am, Friday, 30'th Apr 2021
AtriCure (ATRC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
AtriCure, Inc.'s (ATRC) CEO Mike Carrel on Q1 2021 Results - Earnings Call Transcript
11:22pm, Tuesday, 27'th Apr 2021
AtriCure, Inc.'s (ATRC) CEO Mike Carrel on Q1 2021 Results - Earnings Call Transcript
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
06:02pm, Tuesday, 27'th Apr 2021
AtriCure (ATRC) delivered earnings and revenue surprises of 7.32% and 5.39%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
AtriCure: Q1 Earnings Insights
04:37pm, Tuesday, 27'th Apr 2021
Shares of AtriCure (NASDAQ:ATRC) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 11.11% year over year to ($0.32), which beat t
Preview: AtriCure's Earnings
10:37am, Monday, 26'th Apr 2021
AtriCure (NASDAQ:ATRC) announces its next round of earnings this Tuesday, April 27. Here is Benzinga's everything-that-matters guide for this Tuesday's Q1 earnings announcement.
AtriCure, Inc. (ATRC) CEO Mike Carrel on Q4 2020 Results - Earnings Call Transcript
10:46pm, Tuesday, 23'rd Feb 2021
AtriCure, Inc. (ATRC) CEO Mike Carrel on Q4 2020 Results - Earnings Call Transcript
AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results
08:00am, Tuesday, 02'nd Feb 2021
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will r
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020
07:00am, Monday, 11'th Jan 2021
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced preliminary financia
AtriCure (ATRC) Looks Good: Stock Adds 5.1% in Session
09:47am, Monday, 21'st Dec 2020
AtriCure (ATRC) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference
08:00am, Monday, 14'th Dec 2020
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that
AtriCure, Inc. (ATRC) CEO Mike Carrel on Q3 2020 Results - Earnings Call Transcript
09:52pm, Sunday, 08'th Nov 2020
AtriCure, Inc. (ATRC) CEO Mike Carrel on Q3 2020 Results - Earnings Call Transcript
